Summary & Overview
CPT 3126F: Esophageal Biopsy with Pathology Dysplasia Grading
CPT code 3126F designates a surgical pathology biopsy of esophageal tissue with histologic evaluation for dysplasia and grading of precancerous changes. This code captures a diagnostic pathology service that informs surveillance, treatment planning, and risk stratification for patients with suspected or known esophageal epithelial abnormalities. Nationally, accurate coding of pathology specimens supports quality measurement, appropriate claim adjudication, and population-level monitoring of precancerous lesions.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the code, common settings where the service is performed, and what to expect in payer coverage discussion. The publication summarizes benchmarks and policy-relevant considerations for billing and claims processing, highlights how the code integrates into clinical workflows for gastroenterology and pathology services, and identifies areas where additional documentation or coding clarity is commonly needed.
This national summary is intended to orient clinicians, coding staff, and healthcare administrators to the purpose and clinical significance of CPT code 3126F, and to indicate the types of payer conversations and documentation practices that typically accompany surgical pathology billing for esophageal biopsies.
Billing Code Overview
CPT code 3126F reports a surgical pathology provider’s biopsy of esophageal tissue performed to examine the specimen for dysplasia and to assign a grade. The service is a surgical pathology diagnostic procedure that involves microscopic evaluation of tissue obtained from the esophagus to detect precancerous cellular changes.
Service Type: Surgical pathology — biopsy and histopathologic grading
Typical Site of Service: Hospital outpatient pathology lab, independent pathology laboratory, or surgical pathology service associated with endoscopy suites
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with long-standing gastroesophageal reflux disease (GERD) and progressive dysphagia is referred to a gastroenterologist for upper endoscopy. Endoscopic inspection reveals areas of suspicious mucosal change in the distal esophagus. The gastroenterologist obtains targeted mucosal biopsies during esophagogastroduodenoscopy (EGD) and submits specimens to a surgical pathology provider for histologic evaluation. The surgical pathology provider receives formalin-fixed esophageal tissue, processes and stains the specimens, examines slides microscopically to identify inflammation, intestinal metaplasia (Barrett esophagus), or degrees of dysplasia (low-grade or high-grade), and issues a diagnostic report with grade and recommendations for surveillance or further intervention. Typical site of service is the hospital outpatient endoscopy suite or ambulatory surgery center where EGD with biopsy is performed. Common scenario modifiers include reduced services (52) when limited pathologic evaluation is performed and discontinued procedure (53) when the biopsy is not completed due to patient intolerance or intra-procedural complication.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced Services | Use when the pathology service or biopsy is partially reduced or limited compared with full service (for example, fewer blocks or stains than usual). |